CYCLOBENZAPRINE 10 MG TABLET
For 30 tablets
Pharmacies pay
$0.51 filed
30 × $0.01712 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$4.26 filed
30 × $0.14207 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
8.3× estimated
Medicare paid 8.3× what pharmacies pay.
Part D averages every strength and form sold under “Cyclobenzaprine HCl” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$5.59 estimated
$0.51 + $0.08 (15%) + $5.00 fee per fill = $5.59
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
CYCLOBENZAPRINE 10 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “cyclobenzaprine” and “cyclobenzaprine hydrochloride”, as its NDCs’ listings variously write the nonproprietary name.
FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.
FDA lists 16 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Major Pharmaceuticals and KVK-TECH, Inc.
FDA’s Established Pharmacologic Class for it is Muscle Relaxant.
The NADAC file of 2026-10-14 prices it under 43 NDCs (National Drug Codes); the FDA directory lists 41 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $0.51 for 30 tablets (30 × $0.01712 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 16 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| EXELAN PHARMACEUTICALS, INC. | 6 | $0.01712 per EA filed |
| Rising Pharma Holdings, Inc. | 6 | $0.01712 per EA filed |
| Advagen Pharma Limited | 3 | $0.01712 per EA filed |
| NORTHSTAR RX LLC | 3 | $0.01712 per EA filed |
| Solco Healthcare U.S., LLC | 3 | $0.01712 per EA filed |
| Teva Pharmaceuticals USA, Inc. | 3 | $0.01712 per EA filed |
| TruPharma LLC | 3 | $0.01712 per EA filed |
| Unichem Pharmaceuticals (USA), Inc. | 3 | $0.01712 per EA filed |
| Cipla USA Inc. | 2 | $0.01712 per EA filed |
| Jubilant Cadista Pharmaceuticals Inc. | 2 | $0.01712 per EA filed |
| KVK-TECH, Inc. | 2 | $0.01712 per EA filed |
| American Health Packaging | 1 | $0.01712 per EA filed |
| Aurobindo Pharma Limited | 1 | $0.01712 per EA filed |
| AvPAK | 1 | $0.01712 per EA filed |
| Major Pharmaceuticals | 1 | $0.01712 per EA filed |
| SOLA Pharmaceuticals, LLC | 1 | $0.01712 per EA filed |
| Not listed as a package in the FDA directory | 2 | $0.01712 per EA filed |
All 43 NDCs, with labeler and price
- 00093-3422-01 · Teva Pharmaceuticals USA, Inc. · $0.01712 per EA · eff. 2026-09-23 filed
- 00093-3422-05 · Teva Pharmaceuticals USA, Inc. · $0.01712 per EA · eff. 2026-09-23 filed
- 00093-3422-10 · Teva Pharmaceuticals USA, Inc. · $0.01712 per EA · eff. 2026-09-23 filed
- 00904-7401-61 · Major Pharmaceuticals · $0.01712 per EA · eff. 2026-09-23 filed
- 10702-0007-10 · KVK-TECH, Inc. · $0.01712 per EA · eff. 2026-09-23 filed
- 10702-0007-50 · KVK-TECH, Inc. · $0.01712 per EA · eff. 2026-09-23 filed
- 16571-0783-01 · Rising Pharma Holdings, Inc. · $0.01712 per EA · eff. 2026-09-23 filed
- 16571-0783-10 · Rising Pharma Holdings, Inc. · $0.01712 per EA · eff. 2026-09-23 filed
- 16571-0783-50 · Rising Pharma Holdings, Inc. · $0.01712 per EA · eff. 2026-09-23 filed
- 29300-0415-01 · Unichem Pharmaceuticals (USA), Inc. · $0.01712 per EA · eff. 2026-09-23 filed
- 29300-0415-10 · Unichem Pharmaceuticals (USA), Inc. · $0.01712 per EA · eff. 2026-09-23 filed
- 29300-0415-19 · Unichem Pharmaceuticals (USA), Inc. · $0.01712 per EA · eff. 2026-09-23 filed
- 43547-0400-10 · Solco Healthcare U.S., LLC · $0.01712 per EA · eff. 2026-09-23 filed
- 43547-0400-11 · Solco Healthcare U.S., LLC · $0.01712 per EA · eff. 2026-09-23 filed
- 43547-0400-50 · Solco Healthcare U.S., LLC · $0.01712 per EA · eff. 2026-09-23 filed
- 50268-0191-11 · not listed as a package in the FDA directory · $0.01712 per EA · eff. 2026-09-23 filed
- 50268-0191-15 · AvPAK · $0.01712 per EA · eff. 2026-09-23 filed
- 52817-0332-00 · TruPharma LLC · $0.01712 per EA · eff. 2026-09-23 filed
- 52817-0332-10 · TruPharma LLC · $0.01712 per EA · eff. 2026-09-23 filed
- 52817-0332-50 · TruPharma LLC · $0.01712 per EA · eff. 2026-09-23 filed
- 59746-0177-06 · Jubilant Cadista Pharmaceuticals Inc. · $0.01712 per EA · eff. 2026-09-23 filed
- 59746-0177-10 · Jubilant Cadista Pharmaceuticals Inc. · $0.01712 per EA · eff. 2026-09-23 filed
- 60687-0558-01 · American Health Packaging · $0.01712 per EA · eff. 2026-09-23 filed
- 60687-0558-11 · not listed as a package in the FDA directory · $0.01712 per EA · eff. 2026-09-23 filed
- 64980-0657-01 · Rising Pharma Holdings, Inc. · $0.01712 per EA · eff. 2026-09-23 filed
- 64980-0657-10 · Rising Pharma Holdings, Inc. · $0.01712 per EA · eff. 2026-09-23 filed
- 64980-0657-50 · Rising Pharma Holdings, Inc. · $0.01712 per EA · eff. 2026-09-23 filed
- 65862-0191-05 · Aurobindo Pharma Limited · $0.01712 per EA · eff. 2026-09-23 filed
- 69097-0846-07 · Cipla USA Inc. · $0.01712 per EA · eff. 2026-09-23 filed
- 69097-0846-15 · Cipla USA Inc. · $0.01712 per EA · eff. 2026-09-23 filed
- 70512-0872-10 · SOLA Pharmaceuticals, LLC · $0.01712 per EA · eff. 2026-09-23 filed
- 72603-0312-01 · NORTHSTAR RX LLC · $0.01712 per EA · eff. 2026-09-23 filed
- 72603-0312-02 · NORTHSTAR RX LLC · $0.01712 per EA · eff. 2026-09-23 filed
- 72603-0312-03 · NORTHSTAR RX LLC · $0.01712 per EA · eff. 2026-09-23 filed
- 72888-0014-00 · Advagen Pharma Limited · $0.01712 per EA · eff. 2026-09-23 filed
- 72888-0014-01 · Advagen Pharma Limited · $0.01712 per EA · eff. 2026-09-23 filed
- 72888-0014-05 · Advagen Pharma Limited · $0.01712 per EA · eff. 2026-09-23 filed
- 76282-0283-10 · EXELAN PHARMACEUTICALS, INC. · $0.01712 per EA · eff. 2026-09-23 filed
- 76282-0283-18 · EXELAN PHARMACEUTICALS, INC. · $0.01712 per EA · eff. 2026-09-23 filed
- 76282-0283-27 · EXELAN PHARMACEUTICALS, INC. · $0.01712 per EA · eff. 2026-09-23 filed
- 76282-0283-30 · EXELAN PHARMACEUTICALS, INC. · $0.01712 per EA · eff. 2026-09-23 filed
- 76282-0283-60 · EXELAN PHARMACEUTICALS, INC. · $0.01712 per EA · eff. 2026-09-23 filed
- 76282-0283-90 · EXELAN PHARMACEUTICALS, INC. · $0.01712 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
8 other products in the NADAC file share an FDA nonproprietary name with CYCLOBENZAPRINE 10 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| AMRIX ER 15 MG CAPSULE | $66.23256 per EA filed | We don’t know yet |
| AMRIX ER 30 MG CAPSULE | $66.56709 per EA filed | We don’t know yet |
| CYCLOBENZAPRINE 5 MG TABLET | $0.02197 per EA filed | $0.14207 per EA filed |
| CYCLOBENZAPRINE 7.5 MG TABLET | $0.26288 per EA filed | $0.14207 per EA filed |
| CYCLOBENZAPRINE 10 MG TABLET this page | $0.01712 per EA filed | $0.14207 per EA filed |
| CYCLOBENZAPRINE ER 15 MG CAP | $1.18556 per EA filed | We don’t know yet |
| CYCLOBENZAPRINE ER 30 MG CAP | $1.0822 per EA filed | We don’t know yet |
| FEXMID 7.5 MG TABLET | $0.26288 per EA filed | $0.14207 per EA filed |
| TONMYA 2.8 MG TABLET SL | $29.60952 per EA filed | We don’t know yet |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 43 NDCs’ NADAC prices is $0.01712 per EA filed.
Of the 22 other products in FDA’s Muscle Relaxant class priced per EA, 22 have a higher middle NADAC price and 0 a lower one. The one in the middle is CHLORZOXAZONE 375 MG TABLET, at $0.66652 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $4.26 for 30 tablets, at an average of $0.14207 per EA in 2024 (2024-01-01 to 2024-12-31) for “Cyclobenzaprine HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 7,401,986 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for CYCLOBENZAPRINE 10 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Cyclobenzaprine HCl / Cyclobenzaprine HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Related pages
Its pharmacologic class
Related in the same class
- METHOCARBAMOL 500 MG TABLET
- CARISOPRODOL 250 MG TABLET
- METAXALONE 400 MG TABLET
- ORPHENADRINE ER 100 MG TABLET
- CHLORZOXAZONE 250 MG TABLET